AzTrials
AzTrials

Shoulder PainPhase 2NCT01733914

Contralateral Acupuncture in the Treatment of Chronic Shoulder Pain

A Phase 2 study testing Acupuncture in people with Shoulder Pain, run by Peking University at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

According to traditional Chinese medical theories, a variety of acupuncture formulas can treat diseases such as pain. For example, stimulating acupoints either local or distal to the pain site has been proposed under some conditions. Read more about this study

Who is it for?
Ages 25 to 65 years
Conditions the study is for
Shoulder Pain
What is being tested?
Acupuncture
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
80 participants
Where
1 siteChina
Study dates
Sep 2011to Aug 2013
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Uni-lateral shoulder pain for 6 weeks to 2 years
  • VAS score ≤ 50
  • 25-65 years of age
  • Positive Neer's or Hawkins' signs
  • Accept the informed consent

Who cannot join

  • Shoulder pain of neurological origins
  • Shoulder pain of neck origins
  • Systematic arthritis
  • Wrist problems
  • Previous shoulder, arm, neck or chest fractures or surgeries
  • Mental diseases
Show all 12Show fewer
  • Pregnancy
  • Inability to work for more than 3 months before treatment
  • Diabetes
  • Coagulative dysfunction
  • Corticosterone or physicotherapy experience on the affected shoulder in the last 6 months
  • Failure to accept the informed consent

Trial locations and contacts

1 site in 1 country.

China1 site
  • Province Hospital of Integrative Chinese and Western Medicine, Sichuan

    Chengdu, Sichuan, 100191

Other trials in China

About this study

Official title: Phase II Study of Contralateral Acupuncture in the Treatment of Chronic Shoulder Pain

According to traditional Chinese medical theories, a variety of acupuncture formulas can treat diseases such as pain. For example, stimulating acupoints either local or distal to the pain site has been proposed under some conditions. We hypothesize that stimulating acupoints contralateral to the pain site can successfully treat chronic shoulder pain.

Conditions
Shoulder Pain
Being tested
Acupuncture, Control
Keywords
shoulder pain, acupuncture
Medical subject headings
Shoulder Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AcupunctureProcedure or surgery

    Acupuncture in the following acupoints on the contralateral side of pain site: Jiantong, Zhongzhu, Houxi, and Quchi. The patient will receive 5 treatments (each lasts 30 min) per week for four weeks.

  • ControlOther

    Patients in the waiting list group received conventional orthopaedic therapy including physical exercise, heat or cold therapy. 50 mg diclofenac daily could be taken when the patient suffered from the pain. Injections or cortisone applications of any kind were not allowed.

Study groups in NCT01733914
Study groupRoleWhat they receive
AcupunctureExperimentalExperimental group
Receives: Procedure: Acupuncture
Waiting listSham comparatorControl group
Receives: Other: Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual analogue scale (VAS)

    Pain assessment

    Measured: before and 2, 4, 8 and 16 weeks after treatment start

Secondary outcomes (3)
  1. The MOS item short from health survey (SF-36)

    Quality of life assessment

    Measured: before and 8 and 16 weeks after treatment start

  2. Constant-Murley score

    shoulder motion score

    Measured: before and 2, 4, 8 and 16 weeks after treatment start

  3. DASH score

    Measured: before and 2, 4, 8 and 16 weeks after treatment start

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Nov 2012 (estimated)
  2. Study startSep 2011
  3. Primary completionApr 2013
  4. Study completionAug 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01733914
Sponsor's protocol ID
2007CB512501
Status last verified
May 2014
First submitted
21 Nov 2012
Last updated
14 Apr 2015
Results posted
No
Data monitoring committee
No

Publications

  • Zhang H, Sun J, Wang C, Yu C, Wang W, Zhang M, Lao L, Yi M, Wan Y. Randomised controlled trial of contralateral manual acupuncture for the relief of chronic shoulder pain. Acupunct Med. 2016 Jun;34(3):164-70. doi: 10.1136/acupmed-2015-010947. Epub 2016 Jan 21.

    PubMed 26795764

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Acupuncture in people with Shoulder Pain, run by Peking University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Apr 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual analogue scale (VAS) (time frame: before and 2, 4, 8 and 16 weeks after treatment start). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01733914, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Apr 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in